Literature DB >> 12065066

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.

A Burls1, W Clark, T Stewart, C Preston, S Bryan, T Jefferson, A Fry-Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065066     DOI: 10.3310/hta6090

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  14 in total

Review 1.  Antiviral agents for influenza: a comparison of cost-effectiveness data.

Authors:  Larry D Lynd; Ron Goeree; Bernie J O'Brien
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 2.  Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.

Authors:  Nicola J Cooper; Alexander J Sutton; Keith R Abrams; Allan Wailoo; David Turner; Karl G Nicholson
Journal:  BMJ       Date:  2003-06-07

3.  Antiviral medications for pregnant women for pandemic and seasonal influenza: an economic computer model.

Authors:  Bruce Y Lee; Rachel R Bailey; Ann E Wiringa; Tina-Marie Assi; Richard H Beigi
Journal:  Obstet Gynecol       Date:  2009-11       Impact factor: 7.661

Review 4.  Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.

Authors:  Tom Jefferson; Mark Jones; Peter Doshi; Chris Del Mar
Journal:  BMJ       Date:  2009-12-08

5.  Expediting systematic reviews: methods and implications of rapid reviews.

Authors:  Rebecca Ganann; Donna Ciliska; Helen Thomas
Journal:  Implement Sci       Date:  2010-07-19       Impact factor: 7.327

Review 6.  Reducing the burden of influenza-associated complications with antiviral therapy.

Authors:  B R Ruf; T Szucs
Journal:  Infection       Date:  2009-05-26       Impact factor: 3.553

7.  Economic evaluations of neuraminidase inhibitors to control influenza.

Authors:  Michaël Schwarzinger; Karine Lacombe; Fabrice Carrat
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2003-04       Impact factor: 2.217

8.  Pharmacoeconomics of antiviral therapy for influenza in a Japanese hospital setting.

Authors:  Tadao Inoue; Kazuhiro Watanabe; Naohiko Chonabayashi; Yoshio Uetsuka
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

Review 9.  A scoping review of rapid review methods.

Authors:  Andrea C Tricco; Jesmin Antony; Wasifa Zarin; Lisa Strifler; Marco Ghassemi; John Ivory; Laure Perrier; Brian Hutton; David Moher; Sharon E Straus
Journal:  BMC Med       Date:  2015-09-16       Impact factor: 8.775

Review 10.  Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis.

Authors:  Vanitha A Jagannath; G V Asokan; Zbys Fedorowicz; Tim W R Lee
Journal:  Cochrane Database Syst Rev       Date:  2016-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.